Insider Trading Alert - CNMD, DFT And AL Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, June 15, 2015, 81 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $428.00 to $1,771,500.00.

Highlighted Stocks Traded by Insiders:

Conmed (CNMD) - FREE Research Report

Golden Jo Ann, who is Director at Conmed, sold 1,000 shares at $56.03 on June 15, 2015. Following this transaction, the Director owned 17,043 shares meaning that the stake was reduced by 5.54% with the 1,000-share transaction.

The shares most recently traded at $56.34, up $0.31, or 0.55% since the insider transaction. Historical insider transactions for Conmed go as follows:

  • 4-Week # shares bought: 5,000
  • 4-Week # shares sold: 14,000
  • 12-Week # shares bought: 5,235
  • 12-Week # shares sold: 22,399
  • 24-Week # shares bought: 5,235
  • 24-Week # shares sold: 22,399

The average volume for Conmed has been 149,900 shares per day over the past 30 days. Conmed has a market cap of $1.6 billion and is part of the health care sector and health services industry. Shares are up 25.04% year-to-date as of the close of trading on Monday.

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures and monitoring in the United States, Canada, the United Kingdom, Japan, Australia, and internationally. The stock currently has a dividend yield of 1.42%. The company has a P/E ratio of 52.1. Currently, there are 4 analysts who rate Conmed a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CNMD - FREE

TheStreet Quant Ratings rates Conmed as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, solid stock price performance and expanding profit margins. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full Conmed Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Dupont Fabros Technology (DFT) - FREE Research Report

Foster Jeffrey H, who is Chief Financial Officer at Dupont Fabros Technology, sold 4,936 shares at $31.38 on June 15, 2015. Following this transaction, the Chief Financial Officer owned 23,877 shares meaning that the stake was reduced by 17.13% with the 4,936-share transaction.

The shares most recently traded at $31.17, down $0.21, or 0.66% since the insider transaction. Historical insider transactions for Dupont Fabros Technology go as follows:

  • 4-Week # shares sold: 215,458
  • 12-Week # shares sold: 215,458
  • 24-Week # shares sold: 215,458

The average volume for Dupont Fabros Technology has been 522,200 shares per day over the past 30 days. Dupont Fabros Technology has a market cap of $2.0 billion and is part of the financial sector and real estate industry. Shares are down 5.84% year-to-date as of the close of trading on Monday.

DuPont Fabros Technology, Inc., a real estate investment trust (REIT), engages in the ownership, acquisition, development, operation, management, and lease of large-scale data center facilities in the United States. The stock currently has a dividend yield of 5.37%. The company has a P/E ratio of 27.7. Currently, there are 5 analysts who rate Dupont Fabros Technology a buy, 1 analyst rates it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on DFT - FREE

TheStreet Quant Ratings rates Dupont Fabros Technology as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels, good cash flow from operations, solid stock price performance and notable return on equity. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full Dupont Fabros Technology Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Air Lease (AL) - FREE Research Report

Baer Marc H, who is Evp at Air Lease, sold 1,500 shares at $35.49 on June 15, 2015. Following this transaction, the Evp owned 126,311 shares meaning that the stake was reduced by 1.17% with the 1,500-share transaction.

The shares most recently traded at $35.56, up $0.07, or 0.2% since the insider transaction. Historical insider transactions for Air Lease go as follows:

  • 4-Week # shares bought: 5,000
  • 4-Week # shares sold: 2,000
  • 12-Week # shares bought: 5,000
  • 12-Week # shares sold: 4,000
  • 24-Week # shares bought: 5,000
  • 24-Week # shares sold: 14,100

The average volume for Air Lease has been 539,700 shares per day over the past 30 days. Air Lease has a market cap of $3.7 billion and is part of the services sector and diversified services industry. Shares are up 3.82% year-to-date as of the close of trading on Monday.

Air Lease Corporation engages in the purchase and leasing of commercial jet transport aircraft to airlines worldwide. The company also sells aircraft from its operating lease portfolio to third parties, including other leasing companies, financial services companies, and airlines. The stock currently has a dividend yield of 0.45%. The company has a P/E ratio of 17.8. Currently, there are 8 analysts who rate Air Lease a buy, 1 analyst rates it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on AL - FREE

TheStreet Quant Ratings rates Air Lease as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, expanding profit margins and good cash flow from operations. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full Air Lease Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you liked this article you might like

Voce's Plants Eyes Stockholder Value, Director Battle at Air Methods

Voce's Plants Eyes Stockholder Value, Director Battle at Air Methods

Insider Trading Alert - CNMD, GLAD And IPHI Traded By Insiders

Insider Trading Alert - CNMD, GLAD And IPHI Traded By Insiders

Daniel Plants' Voce Fund Returns 5% as Other Activist Investors Struggle

Daniel Plants' Voce Fund Returns 5% as Other Activist Investors Struggle

Insider Trading Alert - CNMD, AL And CNBKA Traded By Insiders

Insider Trading Alert - CNMD, AL And CNBKA Traded By Insiders

6 Medical Device Stocks to Buy If Ted Cruz Is Elected President

6 Medical Device Stocks to Buy If Ted Cruz Is Elected President